|
SS18 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.341900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.882300E-02 |
| Normal-vs-Stage2 |
7.899600E-01 |
| Normal-vs-Stage3 |
2.772100E-04 |
| Normal-vs-Stage4 |
2.619100E-03 |
| Stage1-vs-Stage2 |
6.679800E-02 |
| Stage1-vs-Stage3 |
4.178400E-02 |
| Stage1-vs-Stage4 |
1.057220E-01 |
| Stage2-vs-Stage3 |
2.384100E-03 |
| Stage2-vs-Stage4 |
9.919300E-03 |
| Stage3-vs-Stage4 |
9.238600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.598200E-03 |
| Normal-vs-AfricanAmerican |
3.459400E-01 |
| Normal-vs-Asian |
9.738000E-02 |
| Caucasian-vs-AfricanAmerican |
4.654200E-01 |
| Caucasian-vs-Asian |
6.556800E-01 |
| AfricanAmerican-vs-Asian |
7.031400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.281000E-03 |
| Normal-vs-Female |
2.132000E-02 |
| Male-vs-Female |
1.825010E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.861900E-02 |
| Normal-vs-Age(41-60Yrs) |
9.682200E-03 |
| Normal-vs-Age(61-80Yrs) |
7.281100E-03 |
| Normal-vs-Age(81-100Yrs) |
2.579200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.020800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.741200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.159630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.224200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.139600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.160400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.096400E-02 |
| Classical-VS-Follicular |
6.407400E-01 |
| Classical-VS-Other |
4.287200E-01 |
| Classical-VS-Normal |
4.052000E-02 |
| Tall-VS-Follicular |
2.643800E-02 |
| Tall-VS-Other |
7.819400E-01 |
| Tall-VS-Normal |
5.594200E-04 |
| Follicular-VS-Other |
4.681200E-01 |
| Follicular-VS-Normal |
3.088600E-01 |
| Other-VS-Normal |
8.422200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.161900E-03 |
| Normal-vs-N1 |
9.818900E-03 |
| N0-vs-N1 |
3.707600E-01 |
|
|
